Jim Cramer

 

Jim Cramer is one of America's most recognized and respected investment pros and media personalities. He runs Action Alerts PLUS, a charitable trust portfolio. In 1996, Jim founded TheStreet, one of the "most visited" financial media websites for individual to institutional investors. Jim also writes daily market commentary for TheStreet's Real Money premium service, and participates in video segments on TheStreet TV. He also serves as host of CNBC's "Mad Money" television program as well as co-host of “Squawk on the Street”.

 


Jim graduated magna cum laude from Harvard College, where he was president of The Harvard Crimson. He went on to earn a law degree from Harvard Law School in 1984. From there Jim joined Goldman Sachs, where he worked in sales and trading. In 1987, he left Goldman to start his own hedge fund. While still managing his fund, Jim helped start Smart Money for Dow Jones.

 


He is the author of Confessions of a Street Addict, You Got Screwed, Jim Cramer's Real Money, Jim Cramer's Mad Money, Jim Cramer's Stay Mad for Life, Jim Cramer's Getting Back to Even and, his newest book, Jim Cramer's Get Rich Carefully. Jim has written for Time magazine and New York magazine and has been featured on CBS' 60 Minutes, NBC's Nightly News with Brian Williams, Meet the Press, Today, The Tonight Show, Late Night and MSNBC's Morning Joe.

Recent Articles By The Author

Rating the Olympic Performances of Comcast, Facebook

Facebook clearly won the gold, though Comcast fared much better than some may think because of viewership beyond traditional television.

Jim Cramer Explains How Mylan is Able to Get Away With High Prices on EpiPens Even in the Face of Criticism

Jim Cramer Explains How Mylan is Able to Get Away With High Prices on EpiPens Even in the Face of Criticism

More competition in the drug industry would prevent situations like the big price hike in Mylan's EpiPens, according to Jim Cramer.

Cramer: Getting to the Heart -- or the Lack of It -- of the EpiPen Issue

Cramer: Getting to the Heart -- or the Lack of It -- of the EpiPen Issue

Competition could be the cure, not demonizing the drugmaker's CEO.

Jim Cramer: If the Yen Stays Strong, HP Will Do Better

Jim Cramer: If the Yen Stays Strong, HP Will Do Better

TheStreet's Action Alerts PLUS Portfolio Manager was disappointed with HP Inc.'s latest quarter.

Jim Cramer: Sears Stock Is Controlled

Jim Cramer: Sears Stock Is Controlled

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said Sears' stock is controlled.